• Search
  • Helpdesk
  • Sales contact
Get your demo
☰

Expert channel

Expanding investor confidence: The strategic value of Patient Reported Outcomes (PROs) in biotech fundraising

biotechfundraisingPRO
For biotech companies engaged in the clinical development of a therapeutic innovation, securing investor trust is as critical as demonstrating the scientific value of their molecule. One powerful yet underleveraged...

Leveraging the potential of Patient Reported Outcome (PRO) data to accelerate therapeutic innovation market access

biotechmarket accessPRO
Patients Reported Outcome (PRO) data provide information on patient health that is obtained directly from the patient.PRO measures serve to...

The critical importance of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies

biotechPRO
In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....

If Patients Want A Better Quality Of Life, Why Isn’t That A Focus For Pharma?

OncologyPatient engagement
A conversation with Frédéric Fiteni, Ph.D., medical oncologist and oncology PRO specialist, University Hospital of Nîmes, and, member of Kayentis Scientific...

Breaking barriers in pediatric clinical trials: perspectives from two expert clinicians

Pediatric
Interview with Begoña Nafria, Head of the Patient Engagement in Research Department at SJD Research Foundation in Spain, and Vivienne...

Bringing the patient’s voice to clinical trials

Patient’s voicePatients insights
In this interview, engagement advocate and cystic fibrosis patient Thomas Smith shares his experiences of being the patient voice in...

Rethinking pediatric clinical trials: guidelines from pediatric experts

PediatricSites perspectives
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s...

Overcoming challenges in long-lasting pediatric clinical trials – Insights from site experts

PediatricSites perspectives
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s...

How DCTs Can Help Pediatric Clinical Research – Insights From Site Experts

PediatricSites perspectives
In this second episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s...

How to avoid common pitfalls when implementing DCT solutions in your clinical trials?

Decentralized trials
In this episode, Ally Hochman, Clinical Operations Project Manager at Kayentis, offers valuable insights into enhancing technology adoption, establishing enduring...

Decentralized trials: keys to achieving success

Decentralized trials
What extra considerations are required for successfully implementing Decentralized Clinical Trials (DCTs) in addition to those for traditional site-based trials?...

Exploring The Specific Challenges Of Pediatric Clinical Trials – Insights From Site Experts

PediatricSites perspectives
In this first episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s...

DCT and health disparities: Insights from a patient advocate

Decentralized trialsPatients insights
Basile Trimbur, Medical and Scientific Officer, Patient Engagement Lead at Kayentis, interviews Trishna Bharadia, Health Advocate & Patient Engagement Advisor,...

Do we have the right understanding of how patients perceive digital clinical trials?

Patients insights
Interview with Trishna Bharadia, Health Advocate & Patient Engagement Advisor on the 1,133 patients survey results conducted by Kayentis in...
Follow us on social media
Subscribe to our newsletter
You may also like

Kayentis introduces its Patient Education Video Library to strengthen clinical...

Expanding investor confidence: The strategic value of Patient Reported Outcomes...

Leveraging the potential of Patient Reported Outcome (PRO) data to...

Gastrointestinal Tract Diseases Research: Moving Towards Patient-Centered Clinical Trials

The critical importance of Patient Reported Outcomes (PROs) for Emerging...

Turning experience into evidence: PROs in IBD clinical research

About the author
Picture of Céline Hollinger

Céline Hollinger

Celine brings almost two decades of communications experience in the life sciences. As a co-founder of a healthcare communication agency for over a decade, she has supported top pharma and innovative healthcare companies. Since April 2019, she has been leading marketing and communication at Kayentis with her innovative strategies.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA